Cue Biopharma, Inc.CUENASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-11.05%
↓ 119% below average
Average (9y)
59.12%
Historical baseline
Range
High:278.27%
Low:-11.05%
Volatility
489.4%
High variability
| Period | Value |
|---|---|
| 2024 | -11.05% |
| 2023 | 5.76% |
| 2022 | -6.70% |
| 2021 | 23.26% |
| 2020 | 22.04% |
| 2019 | -3.70% |
| 2018 | 51.02% |
| 2017 | 232.29% |
| 2016 | 278.27% |
| 2015 | 0.00% |